Class 4 Caution in Use
Fresenius Kabi Limited have informed the MHRA of a packaging error with specific batches of Sodium Chloride Intravenous Infusion 0.9% Freeflex and Freeflex PLUS.
MHRA drug alert date: 22nd May 2024
MHRA Drug alert link: https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-fresenius-kabi-limited-sodium-chloride-0-dot-percent-intravenous-infusion-bp-freeflex-and-freeflex-plus-el-24-a-slash-17
Pip code | Product description | Supplier | Batch Numbers |
8133167 | SODIUM CHLORIDE INF IV 0.9% 500ml | FRESENIUS KABI | 13SKL101 13TAL213 |
Alliance do not stock | SODIUM CHLORIDE INF IV 0.9% 100ml | FRESENIUS KABI | 13SLF242 13TAF173 |
Alliance do not stock | SODIUM CHLORIDE INF IV 0.9% 250ml | FRESENIUS KABI | 13SMF061 13TBF281
|
This is a caution in use only we are not accepting stock returns
Further Information
For more information or medical information queries please email Medical.Information-UK@fresenius-kabi.com or telephone +44 (0) 1928 533575.
For stock control enquiries please contact FK.complaints-uk@fresenius-kabi.com or telephone +44 (0) 1928 533758.